BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 26435415)

  • 1. Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice.
    Li A; Tian X; Zhang X; Huang S; Ma Y; Wu D; Moeckel G; Somlo S; Wu G
    Am J Pathol; 2015 Oct; 185(10):2843-60. PubMed ID: 26435415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.
    Park EY; Sung YH; Yang MH; Noh JY; Park SY; Lee TY; Yook YJ; Yoo KH; Roh KJ; Kim I; Hwang YH; Oh GT; Seong JK; Ahn C; Lee HW; Park JH
    J Biol Chem; 2009 Mar; 284(11):7214-22. PubMed ID: 19098310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
    Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
    J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.
    Tsilosani A; Gao C; Chen E; Lightle AR; Shehzad S; Sharma M; Tran PV; Bates CM; Wallace DP; Zhang W
    J Am Soc Nephrol; 2024 Apr; 35(4):398-409. PubMed ID: 38254271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin.
    Kim I; Ding T; Fu Y; Li C; Cui L; Li A; Lian P; Liang D; Wang DW; Guo C; Ma J; Zhao P; Coffey RJ; Zhan Q; Wu G
    J Am Soc Nephrol; 2009 Dec; 20(12):2556-69. PubMed ID: 19939939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
    Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
    J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
    Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
    Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
    Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
    Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
    Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
    J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-myc downstream-regulated gene 1 is involved in the regulation of cystogenesis in transgenic mice overexpressing human PKD2 gene.
    Kim BH; Park EY; Yoo KH; Choi KM; Kim Y; Seong Jk; Park JH
    Proteomics; 2013 Jan; 13(1):134-41. PubMed ID: 23212942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells.
    Bonon A; Mangolini A; Pinton P; Del Senno L; Aguiari G
    Biochem Biophys Res Commun; 2013 Nov; 441(3):668-74. PubMed ID: 24184483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.
    Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR
    Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystin-2-dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease.
    Jung HJ; Dixon EE; Coleman R; Watnick T; Reiter JF; Outeda P; Cebotaru V; Woodward OM; Welling PA
    Physiol Genomics; 2023 Nov; 55(11):565-577. PubMed ID: 37720991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype.
    Pritchard L; Sloane-Stanley JA; Sharpe JA; Aspinwall R; Lu W; Buckle V; Strmecki L; Walker D; Ward CJ; Alpers CE; Zhou J; Wood WG; Harris PC
    Hum Mol Genet; 2000 Nov; 9(18):2617-27. PubMed ID: 11063721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease.
    Wu G; Tian X; Nishimura S; Markowitz GS; D'Agati V; Park JH; Yao L; Li L; Geng L; Zhao H; Edelmann W; Somlo S
    Hum Mol Genet; 2002 Aug; 11(16):1845-54. PubMed ID: 12140187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.
    Wilk EJ; Howton TC; Fisher JL; Oza VH; Brownlee RT; McPherson KC; Cleary HL; Yoder BK; George JF; Mrug M; Lasseigne BN
    Mol Med; 2023 May; 29(1):67. PubMed ID: 37217845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic inactivation of Pkd2 results in polycystic kidney disease.
    Wu G; D'Agati V; Cai Y; Markowitz G; Park JH; Reynolds DM; Maeda Y; Le TC; Hou H; Kucherlapati R; Edelmann W; Somlo S
    Cell; 1998 Apr; 93(2):177-88. PubMed ID: 9568711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of kidney and liver cyst growth in pkd2(WS25/-) mice.
    Doctor RB; Serkova NJ; Hasebroock KM; Zafar I; Edelstein CL
    Nephrol Dial Transplant; 2010 Nov; 25(11):3496-504. PubMed ID: 20388629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue.
    Ong AC; Ward CJ; Butler RJ; Biddolph S; Bowker C; Torra R; Pei Y; Harris PC
    Am J Pathol; 1999 Jun; 154(6):1721-9. PubMed ID: 10362797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
    Wu G
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.